Cardiac Uptake of 18F Florbetapir in Patients Undergoing Chemotherapy

Status Terminated

Clinical Trial Summary

This is a pilot study designed to assess for relative change in cardiac 18F Florbetapir uptake in patients with AL cardiac amyloidosis after appropriate chemotherapy.

Clinical Trial Description

Current research involving [18F]-florbetapir in relationship to cardiac amyloid has taken advantage of the ability of the radiopharmaceutical to bind specifically to amyloid fibrils. It has previously been established that the degree of radiotracer uptake correlates with the density of Beta-amyloid plaque. The ability to quantify this uptake makes [18F]-florbetapir imaging a potential tool to evaluate cardiac response in patients undergoing therapy for AL amyloidosis. It would provide a much-needed tool to monitor cardiac response to chemotherapy to potentially adjust chemotherapy if response was not adequate. It could also provide a tool by which investigators would be able to evaluate new therapies designed to decrease the burden of formed amyloid fibrils within the heart. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03333551
Study type	Interventional
Source	Medical College of Wisconsin
Contact
Status	Terminated
Phase	Phase 4
Start date	October 1, 2020
Completion date	May 8, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04459169` - Cardiac Amyloidosis : Diagnostic Using Red Flag Signals
Recruiting	`NCT03029026` - The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.
Recruiting	`NCT06034405` - Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
Recruiting	`NCT04915235` - Prevalence and Prognosis of Cardiac Amiloidosis in Turkey
Recruiting	`NCT02966522` - Thalidomide/Dexamethasone Treatment And PET Evaluation In Organ Involvemenet of Cardiac Amyloidosis	Phase 2
Recruiting	`NCT04105634` - Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT	Early Phase 1
Recruiting	`NCT05139797` - Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)
Not yet recruiting	`NCT05593679` - A Multi-center Cardiac PYP Scan Registry in Taiwan.
Not yet recruiting	`NCT04146415` - Diagnosis of Cardiac Amyloidosis With 99mTc-PYP; Comparison Between Planar Imaging, SPECT/CT and Cardiac-dedicated CZT Camera	N/A
Not yet recruiting	`NCT06427304` - Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
Recruiting	`NCT06469372` - Cardiac Amyloidosis Discovery Trial	N/A
Recruiting	`NCT04856267` - Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Completed	`NCT03119558` - PET/MRI Evaluation of Cardiac Amyloid	Early Phase 1
Recruiting	`NCT02798705` - Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis
Not yet recruiting	`NCT04387344` - Morpho-functional Cardiac Modifications in Treated Mutated Transthyretin Cardiac Amyloidosis
Recruiting	`NCT06129656` - Cardiac Amyloidosis Registry of University Hospital Leipzig
Terminated	`NCT01683825` - Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir Positron Emission Tomography	Phase 4
Withdrawn	`NCT04363294` - Targeted Testing for ATTR Among Aortic Stenosis Patients-Pilot	N/A
Not yet recruiting	`NCT04661800` - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis	N/A
Terminated	`NCT03232632` - Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.	Early Phase 1